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Epstein-Barr virus (ebv)-associated t/natural killer (NK) cell lymphoproliferative disease is a systemic illness characterised 
by the clonal proliferation of EBV-infected T or NK 
cells.1–4 Different clinical entities include chronic 
active EBV (CAEBV) infections, EBV-associated hae-
mophagocytic lymphohistiocytosis, severe mosquito 
bite allergies and hydroa vacciniforme. Although EBV-
associated T/NK cell lymphoproliferative disorders 
are primarily found among paediatric patients, several 
reports of adult cases have been published.1,5,6 There is 
a strong racial predisposition for CAEBV infections; 
most cases are described in Japan and Korea with 
predominance of the T/NK cell type, while some have 
been reported in native populations from Mexico, 
Peru and Central America.5–8 In contrast, CAEBV 
infections are rare among Caucasians and African-
Americans.2 However, AB cell type CAEBV has been 
mainly observed in Western countries while the 
prevalence in other racial groups is unknown.2,5–8  
Originally, CAEBV of the T/NK type was referred 
to as chronic or recurrent infectious mononucleosis-
like syndrome.9 Clinical manifestations observed 
among patients with the severe form of the disease 
are variable and appear to be more aggressive in 
adult patients compared to those with childhood-
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abstract: Natural killer (NK) cell lymphoproliferative disorders are uncommon and the Epstein-Barr virus (EBV) 
plays an important aetiological role in their pathogenesis. We report a 20-year-old male with a chronic active EBV 
infection associated with a NK cell lymphoproliferative disorder which had an unusual indolent course. He presented 
to the Sultan Qaboos University Hospital in Muscat, Oman, in December 2011 with a history of intermittent fever and 
coughing. Examinations revealed generalised lymphadenopathy, hepatosplenomegaly, leukocytosis, transaminitis, 
diffuse bilateral lung infiltrates and bone marrow lymphocyte involvement. A polymerase chain reaction (PCR) test 
revealed a high EBV viral load in the peripheral blood cells. The patient received a course of piperacillin-tazobactam 
for Klebsiella pneumoniae, but no active treatment for the lymphoproliferative disorder. However, his lymphocyte 
count, serum lactate dehydrogenase and liver enzymes dropped spontaneously. In addition, EBV PCR copies 
fluctuated and then decreased significantly. He remained clinically asymptomatic over the following four years.
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امللخ�ص: تعد ال�سطرابات التكاثرية اللمفية املزمنة للخاليا الفاتكة الطبيعية قليلة ال�سيوع، ويلعب فريو�س ابي�ستاين–بار دورا مهما يف 
اإحداثها. نتناول هنا حالة �ساب يف الع�رسين من عمره م�ساب بعدوى مزمنة ن�سطة لفريو�س ابي�ستاين–بار ومرتبطة با�سطراب تكاثري 
ملفي مزمن للخاليا الفاتكة، وذا م�سار بطيء التنامي غري معتاد. ح�رس املري�س مل�ست�سفى جامعة ال�سلطان قابو�س يف م�سقط ب�سلطنة 
عمان يف دي�سمرب من عام 2011م. وبح�سب تاريخه املر�سي فقد كان يعاين من حمى متقطعة و�سعال. واأظهر الفح�س اعتالل معمما للغدد 
اللمفاوية، و�سخامة الكبد والطحال، وزيادة الكريات البي�ساء، وارتفاع م�ستوى انزميات ناقالت الأمني، ور�سيحة الرئة املنت�رسة ثنائية 
اجلانب، مع اكتناف ملفاويات نقي العظام. واظهر اختبار تفاعل البويل مرييز الت�سل�سلي حمال كبريا لفريو�س ابي�ستاين–بار يف خاليا الدم 
الطرفية. ومت اإعطاء املري�س جرعات مقررة من امل�ساد احليوي بيربا�سيلني–تازوباكتم لعالج بكرتيا كل�سيال نيموين، ولكنه مل يعط اأي 
عالج ن�سط لال�سطراب التكاثري اللمفي. اإل اأن عدد خالياه اللمفية ون�ساط انزمي نازعة هيدروجني الالكتات، وانزميات الكبد انخف�ست 
تلقائيا. وبالإ�سافة اإىل ذلك فقد متوجت ن�سخ اختبار تفاعل البويل مرييز الت�سل�سلي فريو�س ابي�ستاين–بار يف ثم انخف�ست ب�سورة معنوية. 
وظل املري�س غري مظهر لأي اأعرا�س ملدة اأربعة اأعوام تالية.
كلمات مفتاحية: حمى عدوى فريو�س ابي�ستاين-بار؛ اخللية الفاتكة الطبيعية؛ ال�سطرابات التكاثرية اللمفية؛ التعايف التلقائي؛ عر�س حالة؛ عمان.
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onset disease.6 Clinical features include fever, liver 
dysfunction, splenomegaly, lymphadenopathies and 
cytopaenia, with these being seen more commonly in 
T cell cases.1 This report describes a patient with EBV-
associated NK cell lymphoproliferative disease from 
Oman with an unusual indolent chronic course that 
did not require any therapeutic intervention; to the 
best of the authors’ knowledge, this is the first case of 
this kind reported from the Middle East.
Case Report
A 20-year-old previously healthy male presented 
to the Sultan Qaboos University Hospital, Muscat, 
Oman, in December 2011 with a six-month history 
of intermittent fever and a recent history of coughing. 
He had not lost any weight, did not suffer from night 
sweats and his family history was unremarkable. 
He had no symptoms suggestive of an underlying 
autoimmune disorder or a connective tissue disease. 
Physical examination revealed bilateral non-bulky 
submandibular lymph nodes without skin lesions. The 
rest of the examination was unremarkable. Abdominal 
ultrasonography showed mild hepatosplenomegaly 
with normal echogenicity and no focal lesions. A 
complete blood count revealed leukocytosis (total 
white cell count: 46.2 x 109/L; normal range [NR]: 
2.2–10.0 x 109/L) and lymphocytosis (lymphocyte 
count: 37.3 x 109/L; NR: 1.2–4.0 x 109/L). The 
patient had normal haemoglobin levels (12.2 g/dL; 
NR: 11.5–15.5 g/dL) and a normal platelet count 
(351.0 x 109/L; NR: 140.0–400.0 x 109/L). A blood 
smear showed lymphocytosis with monomorphic large 
granular lymphocytes. Flow cytometry revealed 82% 
lymphocytes, of which 90% were NK cells. These were 
positive for cluster of differentiation (CD) 16, partial 
CD56, CD2, CD7, human leukocyte antigen-D related 
and CD38 cells and negative for surface CD3 and CD5 
cells and T cell receptors α/β and γ/δ. Approximately 
25–30% of the CD56-positive cells were homogenously 
positive for CD8dim. A bone marrow aspirate showed 
33% granular lymphocytes and flow cytometry findings 
similar to those of the peripheral blood cells. Moreover, 
the bone marrow biopsy showed interstitial infiltrate 
of CD8 and granzyme B-positive small lymphocytes. 
An EBV polymerase chain reaction (PCR) test 
revealed a high viral load (116,750 copies/mL). 
A trephine biopsy was positive for EBV by in situ 
hybridisation. Consequently, the diagnosis of an 
EBV-associated NK cell lymphoproliferative disorder 
was made. 
Laboratory investigations revealed high lactate 
dehydrogenase (LDH; 406 U/L; NR: 135–225 U/L), 
aspartate aminotransferase (74 IU/L; NR: 0–38 IU/L), 
alanine transaminase (91 IU/L; NR: 0–41 IU/L), alkaline 
phosphatase (225 IU/L; NR: 40–129 IU/L), indirect 
hyperbilirubinemia (total bilirubin: 25 µmol/L; NR: 
0–17 µmol/L) and C-reactive protein (22 mg/L; NR: 
0–8 mg/L) levels. Serum calcium, uric acid, potassium, 
phosphate and creatinine levels were normal. Serology 
for hepatitis B and C and human immunodeficiency 
virus was negative. Karyotype testing showed normal 
results. A chest X-ray showed bilateral prominent 
reticulonodular changes and left hilar prominence. 
Contrast-enhanced computed tomography (CT) 
of the neck, chest and abdomen revealed small 
subcentimetre-sized lymph nodes in the bilateral 
jugulodigastric, pretracheal, axillary and mesenteric 
areas, as well as slightly enlarged hilar lymph nodes. In 
addition, bilateral small ill-defined nodular pulmonary 
densities were observed. Sputum cultures grew 
Klebsiella pneumoniae; however, bronchoalveolar 
lavage was negative for microorganisms including 
Mycobacterium tuberculosis, fungi and Pneumocystis 
carinii. A transbronchial biopsy revealed an inter-
alveolar infiltrate of granzyme B- and EBV-positive 
lymphocytes. No reactive follicles or granulomata 
were present. 
While a course of piperacillin/tazobactam was 
prescribed to treat the bacterial pneumonia, the 
patient declined any active therapy for his underlying 
lymphoproliferative disorder. He was closely moni-
tored and a spontaneous gradual drop was observed 
in his lymphocyte count, serum LDH levels and liver 
enzymes over the following 12 months. Additionally, 
EBV PCR copies fluctuated and then decreased 
significantly [Figure 1]. The patient’s symptoms 
resolved over a period of two months and he 
remained clinically asymptomatic with a gradually 
decreasing lymphocyte count (4.0 x 109/L) with large 
granular lymphocyte morphology. His serum LDH 
levels remained normal and a repeat CT scan showed 
stable subcentimetre lymphadenopathy in the cervi-
cal, pretracheal and hilar areas, along with mild 
hepatosplenomegaly. The patient remained clinically 
well over the four years following his initial diagnosis.
Discussion
In general, patients with EBV-associated NK cell 
lymphoproliferative disease exhibit large granular 
lymphocytosis, hypersensitivity to mosquito bites, 
skin rashes, defective NK cell activity and high 
immunoglobulin E levels.3,7 The diagnostic criteria 
for this disease entity was first proposed by Okano 
et al. in the absence of apparent features of a known 
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ulceration/proliferation, coronary artery aneurysms, 
central nervous system involvement, myocarditis and 
interstitial pneumonia.11 In addition, these patients 
respond poorly to chemotherapy and have a high 
risk of eventual progression to overt leukaemia and 
lymphomas in the form of extranodal NK/T cell 
lymphomas of nasal type (ENKLs), aggressive NK cell 
leukaemia (ANKL) and peripheral T cell leukaemia 
or lymphomas.1,11,12 Some researchers recommend 
an early bone marrow transplant while the patient is 
in good general health, despite the associated 
transplant-related mortality.1 Further research is 
required to assess the actual prevalence of EBV-
associated T/NK lymphoproliferative disorders and 
improve patient outcomes.
Poor prognostic features which indicate early 
intervention include advanced age at onset (over eight 
underlying disease at the time of diagnosis.10 The 
patient in the current case displayed morphology 
similar to patients with the T cell subtype and an 
immunophenotype of the NK variant. He did not 
undergo testing for NK cell killing activity; however, 
he fulfilled the criteria proposed by Okano et al., 
including persistent infectious mononucleosis-like 
symptoms, unusual patterns of anti-EBV antibodies, 
increased EBV genome in affected tissues (including 
peripheral blood cells) and chronic illness unexplained 
by other known disease processes.10 
The clinical outcome for patients with CAEBV 
infections is reportedly poor and appears to be worse 
for CD4+ T cell cases than NK cell cases.1 CAEBV 
often results in life-threatening complications such 
as haemophagocytic syndrome, disseminated intra-
vascular coagulopathy, hepatic failure, digestive tract 
 
Figure 1A‒C: Graphs showing the significant drop over time in (A) total white cell count, (B) liver enzyme levels and 
(C) Epstein-Barr viral load in a 20-year-old male with an unusual indolent course of chronic active Epstein-Barr virus-
associated natural killer cell lymphoproliferative disorder. The patient declined to undergo any active therapy for the 
disorder and seemed to exhibit a spontaneous recovery.
WBC = white blood cell count; ANC = absolute neutrophil count; Lymphs = lymphocyte count; LDH = lactate dehydrogenase H; AST = aspartate 
aminotransferase; ALT = alanine transaminase; ALP = alkaline phosphatase.
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years old), the presence of thrombocytopaenia (platelet 
count: <120,000/L) and T cell (rather than NK cell) 
associated disease.13 The overall outcome of NK cell-
associated disease is variable. There are reports of some 
patients who eventually developed ENKL and ANKL 
while other cases seem to have indolent courses.1 Two 
indolent cases reportedly achieved complete remission 
with oral acyclovir therapy and weekly intravenous 
cytarabine administration; however, the role of these 
agents in achieving complete remission is not clear.1 
In the current case, the patient appeared to exhibit 
an indolent course despite persistent lymphocytosis, 
generalised lymphadenopathy, initial multi-organ 
involvement (including lung involvement) and poor 
prognostic indicators.
Conclusion
EBV-associated T/NK lymphoproliferative disorders 
are uncommonly seen outside of Japan, Korea and 
Taiwan and are often aggressive. To the best of 
the authors’ knowledge, the patient in this report 
represents the first case from the Middle East with an 
unusual indolent course which resolved spontaneously 
without therapeutic intervention. 
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